143 related articles for article (PubMed ID: 9359430)
21. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
Herdick M; Carlberg C
J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
[TBL] [Abstract][Full Text] [Related]
22. Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.
Yamamoto K; Anami Y; Itoh T
Curr Top Med Chem; 2014; 14(21):2378-87. PubMed ID: 25537068
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3).
Norman AW; Adams D; Collins ED; Okamura WH; Fletterick RJ
J Cell Biochem; 1999 Sep; 74(3):323-33. PubMed ID: 10412035
[TBL] [Abstract][Full Text] [Related]
24. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent.
Swamy N; Kounine M; Ray R
Arch Biochem Biophys; 1997 Dec; 348(1):91-5. PubMed ID: 9390178
[TBL] [Abstract][Full Text] [Related]
25. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.
Mizwicki MT; Keidel D; Bula CM; Bishop JE; Zanello LP; Wurtz JM; Moras D; Norman AW
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12876-81. PubMed ID: 15326291
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
Issa LL; Leong GM; Sutherland RL; Eisman JA
J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
[TBL] [Abstract][Full Text] [Related]
27. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
Belorusova AY; Rochel N
Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
[TBL] [Abstract][Full Text] [Related]
28. Modulators of vitamin D nuclear receptor: recent advances from structural studies.
Belorusova AY; Rochel N
Curr Top Med Chem; 2014; 14(21):2368-77. PubMed ID: 25486941
[TBL] [Abstract][Full Text] [Related]
29. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.
Rochel N; Wurtz JM; Mitschler A; Klaholz B; Moras D
Mol Cell; 2000 Jan; 5(1):173-9. PubMed ID: 10678179
[TBL] [Abstract][Full Text] [Related]
30. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
[TBL] [Abstract][Full Text] [Related]
31. The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription.
Masuyama H; Jefcoat SC; MacDonald PN
Mol Endocrinol; 1997 Feb; 11(2):218-28. PubMed ID: 9013769
[TBL] [Abstract][Full Text] [Related]
32. Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228).
Ismail A; Nguyen CV; Ahene A; Fleet JC; Uskokovic MR; Peleg S
Mol Endocrinol; 2004 Apr; 18(4):874-87. PubMed ID: 14726489
[TBL] [Abstract][Full Text] [Related]
33. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases.
Bury Y; Ruf D; Hansen CM; Kissmeyer AM; Binderup L; Carlberg C
J Invest Dermatol; 2001 May; 116(5):785-92. PubMed ID: 11348471
[TBL] [Abstract][Full Text] [Related]
34. Novel vitamin D receptor ligands having a carboxyl group as an anchor to arginine 274 in the ligand-binding domain.
Fujishima T; Tsuji G; Tanaka C; Harayama H
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):60-2. PubMed ID: 20435140
[TBL] [Abstract][Full Text] [Related]
35. Differential use of transcription activation function 2 domain of the vitamin D receptor by 1,25-dihydroxyvitamin D3 and its A ring-modified analogs.
Peleg S; Nguyen C; Woodard BT; Lee JK; Posner GH
Mol Endocrinol; 1998 Apr; 12(4):525-35. PubMed ID: 9544988
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D receptor 2016: novel ligands and structural insights.
Maestro MA; Molnár F; Mouriño A; Carlberg C
Expert Opin Ther Pat; 2016 Nov; 26(11):1291-1306. PubMed ID: 27454349
[TBL] [Abstract][Full Text] [Related]
38. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
Mizwicki MT; Bishop JE; Norman AW
Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
[TBL] [Abstract][Full Text] [Related]
39. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
Peräkylä M; Molnár F; Carlberg C
Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
[TBL] [Abstract][Full Text] [Related]
40. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
Kimmel-Jehan C; Jehan F; DeLuca HF
Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
